Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical FK506 for Prevention of Immune Reactions Following Penetrating Keratoplasty
NCT00463723Phase 3Terminated
- Sponsor
- University Hospital Freiburg
- Modality
- RNA-Targeting Small Molecules
01
Overview
Phase 3 trial of tacrolimus in corneal transplant rejection (2 arms), sponsored by University Hospital Freiburg. Status: terminated.
02
Drugs
tacrolimus
03
Conditions
corneal transplant rejection
Beyond the preview
Go deeper on NCT00463723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00463723.